Welcome to the Doherty Clinical Trials website

Doherty Clinical Trials Ltd Is Here

Doherty Clinical Trials Ltd is designed to accelerate the development of novel medicines and vaccines for key partners and industry clients. Our primary focus is the safety of our participants through the implementation of high-quality and ethical clinical research.

Currently in development, our facility will be the only of its kind in Australia: purpose-built to deliver human challenge trials (HCTs). Although HCTs are the key differentiator for our business, we add value to clinical development through a range of early-phase clinical solutions, including Phase I healthy volunteer trials.

All trials are supported by broad networks of clinical trial expertise, including some of the world’s leading hospital clinicians and research scientists. We offer clients tailored support for their clinical development objectives through access to comprehensive expertise across Melbourne’s Parkville Biomedical Precinct including the Doherty Institute, The Royal Melbourne Hospital, Murdoch Children’s Research Institute and Walter and Eliza Hall Institute.

If you’d like to find out more, contact us here.

November 6, 2024
Event
Dr Andrew Brockway at AusBiotech 2024

Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024

November 27, 2024
News
Doherty Clinical Trials at the 10th National Institutional Biosafety Committee Forum

Senior Lab Manager, Vanessa Mollard represented Doherty Clinical Trials at the forum in Canberra

June 5, 2024
In the Media
Doherty Clinical Trials on The House of Wellness

Highlighting the vital work of Doherty Clinical Trials and sharing why participants find it so rewarding.

November 16, 2023
News
Doherty Clinical Trials launches the #mRNA Platform Incubator Network

Doherty Clinical Trials launches the #mRNA Platform Incubator Network in collaboration with Moderna and other leading minds in bio-medical research

April 2, 2024
In the Media
In the News - CEO Dr Andrew Brockway interviewed by The Guardian

Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.